The Impact of 3-D Printing on Pharmaceutical Products Liability
Elizabeth Christen authored an article for The MedLaw Update titled “The Impact of 3-D Printing on Pharmaceutical Products Liability.” The article discussed recent advancement in 3-D printed medicines and its intersection with traditional medical regulations and the law.
The medical industry has used 3-D technology for medical devices such as prosthetic limbs, dental implants and surgical screws, and the Food and Drug Administration has approved more than 100 3-D printed medical devices. Pharmaceutical companies are exploring 3D-printed medications and the FDA approved the first, and currently only, 3-D printed medication in 2015. Elizabeth examined the current regulatory climate and potential liability concerns for pharmaceutical manufacturers.
“Regarding potential tort liability, 3-D medical printing brings about a plethora of new considerations,” she said. “Legal questions undoubtedly will include what is a ‘product,’ who is the ‘manufacturer,’ what is the ‘marketplace,’ and who should be liable for a defective 3-D printed medication.”
The material contained in this communication is informational, general in nature and does not constitute legal advice. The material contained in this communication should not be relied upon or used without consulting a lawyer to consider your specific circumstances. This communication was published on the date specified and may not include any changes in the topics, laws, rules or regulations covered. Receipt of this communication does not establish an attorney-client relationship. In some jurisdictions, this communication may be considered attorney advertising.
Meet the Authors
